RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      KCI등재 SCOPUS SCIE

      Alcoholic fatty liver disease elevates estimated coronary heart disease risk to levels comparable with those of nonalcoholic fatty liver disease in the Korean population: a cross-sectional study

      한글로보기

      https://www.riss.kr/link?id=A103919477

      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      다국어 초록 (Multilingual Abstract)

      Background/Aims: A close relationship has been established between nonalcoholic fatty liver disease (NAFLD) andan elevated risk of coronary heart disease (CHD), but little is known about the association between alcoholic fatty liverdisease (AFLD) and CHD risk. The aim of this study was to determine whether AFLD is associated with elevated CHDrisk.
      Methods: We retrospectively enrolled 10,710 subjects out of 11,469 individuals who visited the Konkuk UniversityHealth Care Center for a routine health checkup in 2010. AFLD was diagnosed made when the usual amount of alcoholconsumption exceeded 210 g/week in males and 140 g/week in females for the previous 2 years and when hepaticsteatosis was detected by liver ultrasonography. The 10-year risk for CHD was estimated using the Framingham RiskScore.
      Results: Hepatic steatosis was diagnosed in 4,142 of the 10,710 individuals (38.7%); the remainder (i.e., n=6,568)became the control group. The 4,142 individuals with hepatic steatosis were divided into two groups: NAFLD (n=2,953)and AFLD (n=1,189). The risk of CHD was higher in AFLD (6.72±0.12) than in the control group (5.50±0.04, P<0.001),and comparable to that in NAFLD (7.32±0.07, P=0.02).
      Conclusions: Individuals with AFLD have an elevated 10-year risk of CHD that is comparable to those with NAFLD.
      Therefore, AFLD should be considered a significant risk for future CHD, and preventive measures should be considered earlier.
      번역하기

      Background/Aims: A close relationship has been established between nonalcoholic fatty liver disease (NAFLD) andan elevated risk of coronary heart disease (CHD), but little is known about the association between alcoholic fatty liverdisease (AFLD) and ...

      Background/Aims: A close relationship has been established between nonalcoholic fatty liver disease (NAFLD) andan elevated risk of coronary heart disease (CHD), but little is known about the association between alcoholic fatty liverdisease (AFLD) and CHD risk. The aim of this study was to determine whether AFLD is associated with elevated CHDrisk.
      Methods: We retrospectively enrolled 10,710 subjects out of 11,469 individuals who visited the Konkuk UniversityHealth Care Center for a routine health checkup in 2010. AFLD was diagnosed made when the usual amount of alcoholconsumption exceeded 210 g/week in males and 140 g/week in females for the previous 2 years and when hepaticsteatosis was detected by liver ultrasonography. The 10-year risk for CHD was estimated using the Framingham RiskScore.
      Results: Hepatic steatosis was diagnosed in 4,142 of the 10,710 individuals (38.7%); the remainder (i.e., n=6,568)became the control group. The 4,142 individuals with hepatic steatosis were divided into two groups: NAFLD (n=2,953)and AFLD (n=1,189). The risk of CHD was higher in AFLD (6.72±0.12) than in the control group (5.50±0.04, P<0.001),and comparable to that in NAFLD (7.32±0.07, P=0.02).
      Conclusions: Individuals with AFLD have an elevated 10-year risk of CHD that is comparable to those with NAFLD.
      Therefore, AFLD should be considered a significant risk for future CHD, and preventive measures should be considered earlier.

      더보기

      참고문헌 (Reference)

      1 Choi S-, "The relation between non-alcoholic fatty liver disease and the risk of coronary heart disease in Koreans" 104 : 1953-1960, 2009

      2 Lee HK, "The prevalence and correlates of alcohol use disorders in the United States and Korea-a cross-national comparative study" 44 : 297-306, 2010

      3 Lee HK, "The epidemiology of alcohol use disorders" 13 : 69-75, 2012

      4 World Health Organization, "The Asia-Pacific perspective:redefining obesity and its treatment 2011"

      5 Grant BF, "The 12-month prevalence and trends in DSM-IV alcohol abuse and dependence: United States, 1991-1992 and 2001-2002" 74 : 223-234, 2004

      6 Hasin DS, "Prevalence, correlates, disability, and comorbidity of DSM-IV alcohol abuse and dependence in the United States: results from the national epidemiologic survey on alcohol and related conditions" 64 : 830-842, 2007

      7 Targher G, "Prevalence of nonalcoholic fatty liver diasease and its association with cardiovascular disease among type 2 diabetic patients" 30 : 1212-1218, 2007

      8 Park SH, "Prevalence of alcoholic liver disease among korean adults: results from the fourth Korea National Health and Nutrition Examination Survey, 2009" 46 : 1755-1762, 2011

      9 Wilson PWF, "Prediction of coronary heart disease using risk factor categories" 97 : 1837-1847, 1998

      10 Edens MA, "Non-alcoholic fatty liver disease is associated with cardiovascular disease risk markers" 10 : 412-419, 2009

      1 Choi S-, "The relation between non-alcoholic fatty liver disease and the risk of coronary heart disease in Koreans" 104 : 1953-1960, 2009

      2 Lee HK, "The prevalence and correlates of alcohol use disorders in the United States and Korea-a cross-national comparative study" 44 : 297-306, 2010

      3 Lee HK, "The epidemiology of alcohol use disorders" 13 : 69-75, 2012

      4 World Health Organization, "The Asia-Pacific perspective:redefining obesity and its treatment 2011"

      5 Grant BF, "The 12-month prevalence and trends in DSM-IV alcohol abuse and dependence: United States, 1991-1992 and 2001-2002" 74 : 223-234, 2004

      6 Hasin DS, "Prevalence, correlates, disability, and comorbidity of DSM-IV alcohol abuse and dependence in the United States: results from the national epidemiologic survey on alcohol and related conditions" 64 : 830-842, 2007

      7 Targher G, "Prevalence of nonalcoholic fatty liver diasease and its association with cardiovascular disease among type 2 diabetic patients" 30 : 1212-1218, 2007

      8 Park SH, "Prevalence of alcoholic liver disease among korean adults: results from the fourth Korea National Health and Nutrition Examination Survey, 2009" 46 : 1755-1762, 2011

      9 Wilson PWF, "Prediction of coronary heart disease using risk factor categories" 97 : 1837-1847, 1998

      10 Edens MA, "Non-alcoholic fatty liver disease is associated with cardiovascular disease risk markers" 10 : 412-419, 2009

      11 Kotronen A, "Non-alcoholic and alcoholic fatty liver disease - two diseases of affluence associated with the metabolic syndrome and type 2 diabetes: the FIN-D2D survey" 10 : 237-, 2010

      12 Fan AZ, "Lifetime alcohol drinking pattern is related to the prevalence of metabolic syndrome" The Western New York Health Study (WNYHS) 21 : 129-138, 2006

      13 Matthews DR, "Homeostasis model assessment: Insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man" 28 : 412-419, 1985

      14 Lu H, "High prevalence of coronary heart disease in type 2 diabetic patients with non-alcoholic fatty liver disease" 40 : 571-575, 2009

      15 World Health Organization, "Global status report on alcohol and health 2011"

      16 Expert Panel on Detection, "Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III)" 285 : 2486-2497, 2001

      17 Ruhl CE, "Epidemiology of nonalcoholic fatty liver" 8 : 501-519, 2004

      18 Mandayam S, "Epidemiology of alcoholic liver disease" 24 : 217-232, 2004

      19 Xin X, "Effects of alcohol reduction on blood pressure: A meta-analysis of randomized controlled trials" 38 : 1112-1117, 2001

      20 Patel S, "Comparison of the frequency of coronary artery disease in alcohol-related versus non-alcohol-related endstage liver disease" 108 : 1552-1555, 2011

      21 Bots ML, "Common carotid intima-media thickness and risk of stroke and myocardial infarction: The Rotterdam Study" 96 : 1432-1437, 1997

      22 Chung IJ, "Co-occurring patterns of smoking and alcohol consumption among Korean adolescents" 19 : 252-256, 2010

      23 Falck-Ytter Y, "Clinical features and natural history of nonalcoholic steatosis syndromes" 21 : 17-26, 2001

      24 Kim JH, "Carotid intima-media thickness is increased not only in non-alcoholic fatty liver disease patients but also in alcoholic fatty liver patients" 84 : 149-155, 2011

      25 Lorenz MW, "Carotid intima-media thickening indicates a higher vascular risk across a wide age range: Prospective data from the Carotid Atherosclerosis Progression Study (CAPS)" 37 : 87-92, 2006

      26 Kantartzis K, "Cardiovascular disease in patients with non-alcoholic fatty liver disease" 25 : 276-277, 2012

      27 Fuchs FD, "Association between alcoholic beverage consumption and incidence of coronary heart disease in Whites and Blacks:The Atherosclerosis Risk in Communities Study" 160 : 466-474, 2004

      28 Park SH., "Association between alcohol consumption and metabolic syndrome among korean adults: Nondrinker versus lifetime abstainer as a reference group" 47 : 442-449, 2012

      29 Foerster M, "Alcohol drinking and cardiovascular risk in a population with high mean alcohol consumption" 103 : 361-368, 2009

      30 Fuchs CS, "Alcohol consumption and mortality among women" 332 : 1245-1250, 1995

      31 Room R, "Alcohol and public health" 365 : 519-530, 2005

      32 Korea Centers for Disease Control and Prevention, "2008 The 4th Korea National Health and Nutrition Examination Survey [KNHANES IV-2]"

      더보기

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      주제

      연도별 연구동향

      연도별 활용동향

      연관논문

      연구자 네트워크맵

      공동연구자 (7)

      유사연구자 (20) 활용도상위20명

      인용정보 인용지수 설명보기

      학술지 이력

      학술지 이력
      연월일 이력구분 이력상세 등재구분
      2023 평가예정 해외DB학술지평가 신청대상 (해외등재 학술지 평가)
      2020-01-01 평가 등재학술지 유지 (해외등재 학술지 평가) KCI등재
      2012-06-18 학술지명변경 한글명 : The Korean Journal of Hepatology -> Clinical and Molecular Hepatology
      외국어명 : The Korean Journal of Hepatology -> Clinical and Molecular Hepatology
      KCI등재
      2011-01-18 학술지명변경 한글명 : 대한간학회지 -> The Korean Journal of Hepatology KCI등재
      2010-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2007-01-01 평가 등재학술지 선정 (등재후보2차) KCI등재
      2006-04-10 학회명변경 영문명 : The Korean Association For The Study Of The Liver -> The korean Association for the Study of the Liver KCI등재후보
      2006-01-01 평가 등재후보 1차 PASS (등재후보1차) KCI등재후보
      2005-06-27 학술지명변경 외국어명 : The Korean Association for The Study of The Liver -> The Korean Journal of Hepatology KCI등재후보
      2004-01-01 평가 등재후보학술지 선정 (신규평가) KCI등재후보
      더보기

      학술지 인용정보

      학술지 인용정보
      기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
      2016 0.11 0.11 0.16
      KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
      0.16 0.15 0.442 0.03
      더보기

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼